纳米载体在巴顿病治疗中的使用:系统性审查
Larissa Henke1, Ali Ghorbani2, Sara E Mole3
1Division of Biosciences, University College London, London WC1E 6BT, UK.
International journal of pharmaceutics
|December 18, 2024
概括
纳米粒子和细胞外囊泡显示出通过穿越血脑和血眼屏障来治疗巴顿病 (神经神经状脂症) 的前景. 这些纳米载体可以向受影响的组织提供基因,酶或mRNA疗法.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 生物技术是生物技术.
背景情况:
- 巴顿病 (神经神经状脂症) 是一组严重的儿科 lysosomal 储存障碍.
- 这种情况会导致渐进的神经退行和视力丧失,原因是中枢神经系统和视网膜损伤.
- 目前的治疗策略面临着克服血脑和血眼屏障的挑战.
研究的目的:
- 审查纳米粒子和细胞外囊泡作为巴顿病的药物输送系统的潜力.
- 探索这些纳米载体在跨越生物障碍以进行向疗法的有效性.
- 评估它们在基因,酶或mRNA替代疗法中的应用,用于溶解体储存障碍.
主要方法:
- 对纳米载体在溶酶体储存障碍中的应用进行系统审查.
- 对纳米粒子和细胞外囊泡在穿越血脑和血眼屏障方面的能力进行分析.
- 对 lysosomes 的纳米载体准效率的评估.
主要成果:
- 纳米颗粒和细胞外囊泡可以封装治疗货物进行输送.
- 这些纳米载体显示出穿越血脑和血眼屏障的能力.
- 它们显示出在受影响组织中有效向 lysosomal 的潜力.
结论:
- 纳米载体代表了一种有前途的战略,用于在巴顿病中向大脑和眼睛提供治疗.
- 对于溶酶体储存障碍,需要对基于纳米载体的治疗方法进行进一步的研究.
- 克服生物障碍是成功治疗巴顿病的关键.
相关概念视频
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...